Efficiency of surgical treatment of multidrug-resistant Pulmonary Tuberculosis within the DOTS-PLUS program
https://doi.org/10.20538/1682-0363-2009-1-85-91
Abstract
Efficiency of the surgical treatment of pulmonary tuberculosis for multidrug-resistant (MDR TB) tuberculosis patients was analyzed. Seventy DOTS-PLUS patients with various clinical forms of pulmonary tuberculosis and Mycobacterium resistance from 3 to 8 antituberculosis drugs have been operated. Positive clinical results have been achieved for 65 (92,8%) patients. Indications for surgical treatment for patients with MDR TB have been developed. To ensure positive outcomes of the surgical interventions, main objective is the development of so-called a favorable preoperative environment during the preoperative phase. It includes switching on intensive chemotherapy and pathogenetic methods of treatment.
About the Authors
A. K. StrelisRussian Federation
A. A. Strelis
Russian Federation
O. V. Anastasov
Russian Federation
Ye. V. Nekrasov
Russian Federation
V. K. Raskoshnykh
Russian Federation
A. I. Zadorozniy
Russian Federation
Ye. A. Gubin
Russian Federation
D. Yu. Schegertzov
Russian Federation
O. Yu. Khristenko
Russian Federation
G. V. Yanova
Russian Federation
References
1. Залескис Р. Роль хирургических методов в лечении туберкулеза//Проблемы туберкулеза. 2001. № 9. С. 3-5
2. Краснов Д.В., Андренко А.А. и др. Возможности хирургического лечения больных деструктивным туберкулезом легких при полирезистентности возбудителя//Туберкулез сегодня. Материалы VII Российского съезда фтизиатров. М., 2003. С. 282
3. Мишин В.Ю., Аксенова К.И., Григорьев Ю.Г. и др. Лекарственно-устойчивый туберкулез легких. М., 2005
4. Репин Ю.М., Елькин А.В, Оттян Т.Ф. и др. Значение лекарственной устойчивости микобактерий в хирургии туберкулеза легких//Проблемы туберкулеза. 2001. № 9. С. 6-9
5. Соколова Г.Б. Новые технологии химиотерапии туберкулезной инфекции. М., 2000
6. Стрелис А.К. Современная фтизиатрия и проблемы туберкулеза XXI века: Актовая речь. Томск, 1999
7. Iseman M.D. MDR-TB and the developing world -a problem no longer to be ignored: the WHD announces «DOTS PLUS» strategy//J. Tuberc. Lung Dis. 1998. V. 2. № 11. P. 867
8. Iseman, M.D., Madsen L.A., Goble M., Pomerant M. Surgical intervention in the treatment of pulmonary disease caused by drug-resistant Mycobacterium tuberculosis//Am. Rev. Respir. Dis. 1990. V. 141. № 3. P. 623-625
9. Farmer P.E., Konones A.S., Borisov S.E. et al. Recrudescent tuberculosis in the Russian Federation//The Global Impact of Drug-Resistant tuberculosis. Boston: Harvard Medical School and Open Society Institute, 1999
10. Pomerantz B.J., Cleveland J.C., Olson H.K., Pomerantz M. Pulmonary resection for multi-drug resistance tuberculosis//Thorac. Cardiovasс. surg. 2001. V. 121. № 3. P. 448-453
Review
For citations:
Strelis A.K., Strelis A.A., Anastasov O.V., Nekrasov Ye.V., Raskoshnykh V.K., Zadorozniy A.I., Gubin Ye.A., Schegertzov D.Yu., Khristenko O.Yu., Yanova G.V. Efficiency of surgical treatment of multidrug-resistant Pulmonary Tuberculosis within the DOTS-PLUS program. Bulletin of Siberian Medicine. 2009;8(1):85-91. (In Russ.) https://doi.org/10.20538/1682-0363-2009-1-85-91